Boston Scientific Corporation vs Ryanair Holdings plc — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Ryanair Holdings plc trades at $60.24 (market cap $29.63B). The key difference: Boston Scientific Corporation is far larger — about 2.5× Ryanair Holdings plc's market cap, and Ryanair Holdings plc pays a 1.51% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | RYAAY | |
|---|---|---|
Market Cap | $74.19B | $29.63B |
Sector | Health | Industrials |
52-Week High | $108.14 | $73.82 |
52-Week Low | $42.63 | $53.24 |
Enterprise Value | $86.27B | $26.61B |
Dividend Yield | — | 1.51% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →